首页> 外文期刊>Pathology oncology research: POR >Immunohistochemical Evaluation of 95 Bone Marrow Reactive Plasmacytoses
【24h】

Immunohistochemical Evaluation of 95 Bone Marrow Reactive Plasmacytoses

机译:95种骨髓反应性浆细胞增生症的免疫组织化学评估

获取原文
获取外文期刊封面目录资料

摘要

We histologically and immunohistochemically studied 95 bone marrow (BM) reactive plasmacytoses. Ten biopsies from plasma cell myeloma (PCM) patients served as a control group. In addition, we studied 10 monoclonal gammopathy of undetermined significance (MGUS) cases. Histologically, plasmacytosis varied between 5% and 25% with an interstitial pattern of plasma cell (PC) distribution being characteristically displayed. Immunohistochemically, we did not find any CD56/NCAM nor cyclin D1 expression in all biopsies (95 of 95, 100%), not even a weak, doubtful one; PCs were all polyclonal and CD138 positive. On the contrary, myeloma-associated PCs showed monoclonality for κ- or λ- light chain and strong CD56/NCAM immunoreactivity (8 of 10, 80%); four of them were cyclin D1 positive. Osteoblasts exhibited similar CD56/NCAM expression in both groups. Our data confirm the diagnostic utility of CD56/NCAM in the phenotypic characterization of polyclonal plasma cells, suggesting an important role of this particular immunomarker in the BM trephine study of polyclonal versus neoplastic plasmacytic infiltrations.
机译:我们在组织学和免疫组织化学上研究了95种骨髓(BM)反应性浆细胞酶。来自浆细胞骨髓瘤(PCM)患者的十次活检作为对照组。此外,我们研究了10例意义不明的单克隆丙种球蛋白病(MGUS)。组织学上,浆细胞增多症在5%至25%之间变化,并以浆细胞(PC)分布的间隙模式为特征。从免疫组织化学的角度,我们在所有活检组织中均未发现任何CD56 / NCAM或细胞周期蛋白D1的表达(95个中有95个,100%),甚至没有一个薄弱的,可疑的组织。 PC均为多克隆且CD138阳性。相反,与骨髓瘤相关的PCs对κ或λ轻链具有单克隆性,并具有很强的CD56 / NCAM免疫反应性(10 / 8,80%)。其中四个是细胞周期蛋白D1阳性。两组中成骨细胞均显示相似的CD56 / NCAM表达。我们的数据证实了CD56 / NCAM在多克隆浆细胞表型表征中的诊断效用,表明该特定免疫标志物在BM酪氨酸多克隆与肿瘤性浆细胞浸润的BM研究中具有重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号